Ganoderma Lucidum/Reishi Extract - HY-159059
Nur noch %1 verfügbar
Catalog #
HY-159059
Ab
26,00 €
Ganoderma Lucidum/Reishi Extract is a Ganoderma lucidum extract. Ganoderma Lucidum/Reishi Extract reduces the expression of c-Myc, BCL-2, BCL-XL, TERT, PDGFB, eIF4G, Survivin, β-catenin, and eIF4E. Ganoderma Lucidum/Reishi Extract downregulates the gene expression of MMP-9. Ganoderma Lucidum/Reishi Extract upregulates the expression of IL8. Ganoderma Lucidum/Reishi Extract is applicable to the research of inflammatory breast cancer. Ganoderma Lucidum is used in the research of various diseases, such as allergy, arthritis, hypertension, neurasthenia, inflammation, and cancer[1][2].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-159059/Ganoderma-Lucidum-Reishi-Extract-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | COVID-19-immunoregulation |
| Storage | 4°C (Powder, sealed storage, away from moisture and light) |
| MWT | N/A |
| Solubility | H2O : 4 mg/mL (ultrasonic;warming;heat to 60°C) |
| Clinical Information | No Development Reported |
| Target | Bcl-2 Family;c-Myc;Eukaryotic Initiation Factor (eIF);Interleukin Related;MMP;Survivin;β-catenin |
| Application: | COVID-19-immunoregulation |
|---|